CD2 related immunoregulation in oral cancer

Krishnan Nair, 1988, Clinical profile of 2007 oral cancers in Kerala, India, Ann Dent, 47, 23 Balaram, 1988, Immune function in malignant cervical neoplasia: a multiparameter analysis, Gynaecol Oncol, 31, 409, 10.1016/S0090-8258(88)80025-8 Balaram, 1988, Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer—immune responses, Neoplasma, 35, 617 Balaram, 1984, Leucocyte adherence inhibition assay (LAI) in cancer of the oral cavity, Eur J Clin Oncol, 20, 891, 10.1016/0277-5379(84)90160-3 Scully, 1982, Immunological abnormalities in oral carcinoma and oral keratosis, J Clin Lab Immunol, 8, 113 Platsoucas, 1991, Human suppressor factors inhibiting lymphocyte proliferation and antibody production, Cancer Bull, 43, 17 Moghe, 1980, Demonstration of inhibitory factors affecting cell mediated immunity in patients with Hodgkin's disease, Eur J Cancer, 16, 937, 10.1016/0014-2964(80)90332-1 Herberman, 1980 Gupta, 1984, Serum blocking factors in carcinoma, Ind J Cancer, 21, 11 Pillai, 1988, Natural cytotoxicity and serum blocking in malignant cervical neoplasia, J Exp Clin Cancer Res, 7, 251 Saji, 1988, Clinical studies on serum immunosuppressive acidic protein IAP and ferritin in gastric cancer patients with special reference to pre-operative value and influence of surgical stress, J Surg Oncol, 33, 215, 10.1002/jso.2930330402 Yamagata, 1977, Immunosuppressive effect of sera of cancer patients, Acta Obstet Gynaecol Jpn, 29, 441 Peterson, 1987, Monoclonal antibody and ligand binding sites of the T cell erythrocyte receptor (CD2), Nature, 329, 842, 10.1038/329842a0 Breitmeyer, 1987, The T11 (CD2) molecule is functionally linked to the T3Ti T cell receptor in the majority of T cells, J Immunol, 139, 2899, 10.4049/jimmunol.139.9.2899 Krensky, 1983, The functional significance, distribution and structure of LFA-1, LFA-2 and LFA-3; Cell Surface antigens associated with CTL-target interactions, J Immunol, 131, 611, 10.4049/jimmunol.131.2.611 Palacios, 1982, Is the E receptor on human T lymphocytes a “negative signal receptor”?, J Immunol, 129, 2479, 10.4049/jimmunol.129.6.2479 Tadmori, 1985, Functional properties of the 50 KD protein associated with the E receptor on human T lymphocytes: suppression of IL-2 production by anti-P50 monoclonal antibodies, J Immunol, 134, 1709, 10.4049/jimmunol.134.3.1709 Mooingeon, 1989, The structural biology of CD2, Immunol Res, 111, 110 Brottier, 1985, T cell activation via CD2 (T, gp50) molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6T11 epitopes, J Immunol, 135, 1624, 10.4049/jimmunol.135.3.1624 Brocon, 1989, The CD2 antigen associates with the T cell antigen receptor CD3 antigen complex on the surface of human T lymphocytes, Nature, 339, 551, 10.1038/339551a0 Yang, 1986, A common pathway for T lymphocyte activation involving both the CD3Ti complex and CD2 sheep erythrocyte receptor determinants, J Immunol, 137, 1097, 10.4049/jimmunol.137.4.1097 Koyasu, 1990, Role of interaction of CD2 molecules with lymphocyte function associated antigen 3 in T cell recognition of nominal antigen, 87, 2603 Blue, 1989, Regulation of CD4 and CD8 surface expression on human thymocyte populations by triggering through CD2 and the CD3-T cell receptor, J Immunol, 142, 374, 10.4049/jimmunol.142.2.374 Bierer, 1989, T lymphocytes activation. The biology and function of CD2 and CD4, Immunol Rev, 111, 268, 10.1111/j.1600-065X.1989.tb00549.x Breitmeyer, 1989, Sheep erythrocyte rosetting induces multiple alterations in T lymphocyte function: Inhibition of T cell receptor activity and stimulation of T11CD2, Cell Immunol, 123, 118, 10.1016/0008-8749(89)90273-6 Digeon, 1973, Detection of circulating immune complexes by simplified assays with polyethylene glycol, J Immunol Methods, 16, 165, 10.1016/0022-1759(77)90051-5 Lowry, 1951, Protein measurement with the Folin phenol reagent, J Biol Chem, 193, 265, 10.1016/S0021-9258(19)52451-6 Bland, 1987 Kitaoka, 1991, Adult T cell leukemia derived factor/theoredoxin exists in human serum, 32A, 892 Shatsky, 1989, Histidine rich glycoprotein blocks T cell rosette formation and modulates both T cell activation and immuno regulation, J Biol Chem, 264, 8254, 10.1016/S0021-9258(18)83177-5